Sentinus LLC’s Cardinal Health CAH Stock Holding History

Sentinus LLC’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$225K	Sell	948 -72	-7%	-$15K	0.02%	573
2026 Q1	$216K	Buy	+1,020	New	+$220K	0.02%	536

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Sentinus LLC's CAH Position: Q2 2026 in Review

Sentinus LLC reduced its Cardinal Health (CAH) stake by 7.1% in Q2 2026, selling an estimated $15K and leaving 948 shares worth $225K. The position accounts for 0.02% of the portfolio, ranked #573.

Sentinus LLC first reported a position in CAH in Q1 2026 and has held it in 2 quarters since. 1,499 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Sentinus LLC held 948 shares of Cardinal Health worth $225K as of Q2 2026.
Sentinus LLC sold 72 Cardinal Health shares in Q2 2026, an estimated $15K.
Cardinal Health made up 0.02% of Sentinus LLC's portfolio in Q2 2026, its #573 holding.
Sentinus LLC first reported a position in Cardinal Health in Q1 2026 and has held it in 2 quarters since.
1,499 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Sentinus LLC's 13F filing for Q2 2026, filed 11 Aug 2026.